Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative Subjects
Lindsey R. Baden(Brigham and Women's Hospital), Nina D. Russell(New York Blood Center), Barney S. Graham(National Institutes of Health), Olivier Defawe(Infectious Disease Research Institute), Nidhi Kochar(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cecilia Morgan(Fred Hutch Cancer Center), Georgia D. Tomaras(National Institutes of Health), Dan H. Barouch(Beth Israel Deaconess Medical Center), M. Cardinali(National Institute of Allergy and Infectious Diseases), Kara Brandariz(Beth Israel Deaconess Medical Center), M. Juliana McElrath(Fred Hutch Cancer Center), Magdalena E. Sobieszczyk(Columbia University Irving Medical Center), Raphael Dolin(Beth Israel Deaconess Medical Center), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), William A. Blattner(Unknown)
Cited by 25
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k